Literature DB >> 5637558

Cardio-circulatory effects of beta-adrenergic blockade in organic heart disease. Comparison between propranolol and CIBA 39,089-Ba.

T Grandjean, J L Rivier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5637558      PMCID: PMC459207          DOI: 10.1136/hrt.30.1.50

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  23 in total

1.  Long term treatment of paroxysmal cardiac arrhythmias with propranolol.

Authors:  A Harris
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

2.  Clinical observations on the use of propranolol in disorders of cardiac rhythm.

Authors:  P Szekely; F Jackson; N A Wynne; J K Vohra; G A Batson; W I Dow
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

3.  Effects of beta adrenergic blockade on heart size.

Authors:  D A Chamberlain
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

4.  Treatment of cardiac arrhythmias in unanesthetized patients. Role of adrenergic beta receptor blockade.

Authors:  J C Bath
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

5.  The prophylactic value of propranolol in angina pectoris.

Authors:  R Rabkin; D P Stables; N W Levin; M M Suzman
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

6.  Cardiac output after beta-adrenergic blockade in ischaemic heart disease.

Authors:  J Hamer; E Sowton
Journal:  Br Heart J       Date:  1965-11

7.  Effect of propranolol in myocardial infarction.

Authors:  P J Snow
Journal:  Lancet       Date:  1965-09-18       Impact factor: 79.321

8.  Effect of beta adrenergic blockade on the hemodynamic responses to epinephrine in man.

Authors:  W S Harris; C D Schoenfeld; R H Brooks; A M Weissler
Journal:  Am J Cardiol       Date:  1966-04       Impact factor: 2.778

9.  Propranolol and angina pectoris.

Authors:  S Wolfson; R A Heinle; M V Herman; H G Kemp; J M Sullivan; R Gorlin
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

10.  Hemodynamic changes after beta adrenergic blockade.

Authors:  E Sowton; J Hamer
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

View more
  11 in total

1.  An analysis of skin prick test reactions in 656 asthmatic patients.

Authors:  D J Hendrick; R J Davies; M F D'Souza; J Pepys
Journal:  Thorax       Date:  1975-02       Impact factor: 9.139

2.  Comparative effects of beta adrenergic blocking drugs.

Authors:  E Sowton; D S Das Gupta; I Baker
Journal:  Thorax       Date:  1975-02       Impact factor: 9.139

3.  Clinical evaluation of oxprenolol in angina pectoris.

Authors:  G Sandler; A Pistevos
Journal:  Br Heart J       Date:  1972-08

4.  Beta-adrenergic blocking activity and haemodynamic effects in man of Kö 1313, a new beta-adrenergic antagonist.

Authors:  H J Gilfrich; K H Rahn; R F Nicolescu
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

Review 5.  Beta receptor antagonists in the treatment of heart failure.

Authors:  H Persson; L Erhardt
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

Review 6.  Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.

Authors:  D G Gibson
Journal:  Drugs       Date:  1974       Impact factor: 9.546

7.  Effects of alpha- and beta-receptor blockade on systolic time intervals.

Authors:  F Frei; P Imhof; U C Dubach
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

Review 8.  Beta-adrenergic receptor blocking drugs in hypertension.

Authors:  F O Simpson
Journal:  Drugs       Date:  1974       Impact factor: 9.546

9.  Use of oxprenolol in cardiac arrhythmias associated with acute myocardial ischaemia.

Authors:  G Sandler; A C Pistevos
Journal:  Br Med J       Date:  1971-01-30

10.  Influence of intravenous beta-adrenergic blockade with or without partial agonist activity upon plasma cyclic AMP and catecholamines in healthy subjects.

Authors:  C Gennari; G Pollavini; R Nami; G Francini; C Bianchini; P Verdecchia
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.